ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

ClinicalTrials.gov ID: NCT06524739

Public ClinicalTrials.gov record NCT06524739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 3:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immunoglobulin, HIZENTRA®) in Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)

Study identification

NCT ID
NCT06524739
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CSL Behring
Industry
Enrollment
16 participants

Conditions and interventions

Interventions

  • IgPro20 Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2024
Primary completion
Jun 19, 2025
Completion
Jul 10, 2025
Last update posted
Apr 12, 2026

2024 – 2025

United States locations

U.S. sites
34
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
University of Alabama Hospital at Birmingham Birmingham Alabama 35294-1152
Center for Complex Neurology, EDS & POTS Phoenix Arizona 85006
Mayo Clinic Arizona Scottsdale Arizona 85259
Arkansas Cardiology Clinic - Little Rock Little Rock Arkansas 72205
UC San Diego Health La Jolla California 92037
University of california Irvine Orange California 92868
National Jewish Health Denver Colorado 80206
Hope Research Network Miami Florida 33166
Well Pharma Medical Research, Corp Miami Florida 33173
Velocity Clinical Research, Savannah Savannah Georgia 31406
LSU Health Sciences Center New Orleans Louisiana 70112
Velocity Clinical Research, Metairie New Orleans Louisiana 70119
Johns Hopkins Bayview Medical Center PMR Baltimore Maryland 21224
Mass General Brigham (Massachusetts General Hospital) Belmont Massachusetts 02478
Profound Research LLC at Millennium Affiliated Physicians Farmington Hills Michigan 48334
Velocity Clinical Research - Lincoln Lincoln Nebraska 68510
Dysautonomia Clinic Buffalo New York 14221
NYU Langone Health South Shore Neurologic Associates Patchogue New York 11772
Duke University Medical Center Durham North Carolina 27710
Bernstein Clinical Research Center Cincinnati Ohio 45236
University Hospital Cleveland Medical Center Cleveland Ohio 44195
Hightower Clinical Oklahoma City Oklahoma 73134
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104
Velocity Clinical Research - Union Union South Carolina 29379
Vanderbilt University Medical Center Nashville Tennessee 37232
UT Austin Dell Medical School Austin Texas 78712
University of Texas Southwestern Medical Center Dallas Texas 75390
Prolato Clinical Research Center Houston Texas 77054
Sunbeam Clinical Research McKinney Texas 75069
University of Texas Health Science Center San Antonio Texas 78229
Bateman Horne Center Salt Lake City Utah 84102
Metrodora Institute West Valley City Utah 84119
Velocity Clinical Research - Hampton Hampton Virginia 23666
VCU Health Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06524739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06524739 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →